PE20070010A1 - Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d - Google Patents
Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase dInfo
- Publication number
- PE20070010A1 PE20070010A1 PE2006000563A PE2006000563A PE20070010A1 PE 20070010 A1 PE20070010 A1 PE 20070010A1 PE 2006000563 A PE2006000563 A PE 2006000563A PE 2006000563 A PE2006000563 A PE 2006000563A PE 20070010 A1 PE20070010 A1 PE 20070010A1
- Authority
- PE
- Peru
- Prior art keywords
- eno
- oxo
- carboxyl
- class
- penems
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 229940116108 lactase Drugs 0.000 title 1
- 150000002961 penems Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- -1 IMIDAZO [2,1-b] [1,3] BENZOTHIAZOL-2-YLMETHYLENE Chemical class 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- NOJNFULGOQGBKB-UHFFFAOYSA-M sodium;3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoate Chemical compound [Na+].C1=NC(OCC)=CC=C1C(C=C1)=CC=C1CN1C2=CC=C(OCC=3N=CC(C)=CC=3)C=C2C(SC(C)(C)C)=C1CC(C)(C)C([O-])=O NOJNFULGOQGBKB-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE A Y B SON CADA UNO H, HETEROARILO TRICICLICO FUSIONADO OPCIONALMENTE SUSTITUIDO; X ES S, O; R5 ES H, ALQUILO C1-C6, CICLOALQUILO C5-C6, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: ACIDO (5R,6Z)-6-(IMIDAZO[2,1-b][1,3]BENZOTIAZOL-2ILMETILENO)-7-OXO-4-TIA-1-AZABICICLO[3.2.0]HEPT-2-ENO-2-CARBOXILICO; SAL DE SODIO DE ACIDO(5R),(6Z)-6-(IMIDAZO[1.2-a]QUINOXALIN-2-ILMETILENO)-7-OXO-4-TIA-1-AZABICICLO[3.2.0]HEPTO-2-ENO-2-CARBOXILICO; ACIDO 6-(5-ETOXI-7,8-DIHIDRO-6H-3,4,8b-TRIAZA-AS-INDACEN-2-ILMETILENO)-7-OXO-4-TIA-1-1-AZA-BICICLO[3.2.0]HEPT-2-ENO-2-CARBOXILICO; ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS INHIBEN LAS ENZIMAS DE LA CLASE D UTILES EN EL TRATAMIENTO DE INFECCIONES BACTERIALES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68622105P | 2005-06-01 | 2005-06-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20070010A1 true PE20070010A1 (es) | 2007-01-12 |
Family
ID=37836305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000563A PE20070010A1 (es) | 2005-06-01 | 2006-05-31 | Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060276446A1 (es) |
| EP (1) | EP1885358A2 (es) |
| JP (1) | JP2008542376A (es) |
| CN (1) | CN101189010A (es) |
| AR (1) | AR054467A1 (es) |
| AU (1) | AU2006287938A1 (es) |
| BR (1) | BRPI0611491A2 (es) |
| CA (1) | CA2610478A1 (es) |
| GT (1) | GT200600235A (es) |
| MX (1) | MX2007015173A (es) |
| PE (1) | PE20070010A1 (es) |
| SV (1) | SV2007002555A (es) |
| TW (1) | TW200716104A (es) |
| WO (1) | WO2007030166A2 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR039774A1 (es) * | 2002-05-01 | 2005-03-02 | Wyeth Corp | 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas |
| AR039475A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa |
| TW200716102A (en) * | 2005-06-01 | 2007-05-01 | Wyeth Corp | Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors |
| US8524304B2 (en) | 2005-11-23 | 2013-09-03 | The Coca-Cola Company | High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith |
| US8512789B2 (en) | 2005-11-23 | 2013-08-20 | The Coca-Cola Company | High-potency sweetener composition with dietary fiber and compositions sweetened therewith |
| US8945652B2 (en) | 2005-11-23 | 2015-02-03 | The Coca-Cola Company | High-potency sweetener for weight management and compositions sweetened therewith |
| JP2012121809A (ja) * | 2009-02-26 | 2012-06-28 | Eisai R & D Management Co Ltd | 多環式化合物の製造法およびその中間体 |
| US20110288063A1 (en) * | 2010-05-19 | 2011-11-24 | Naeja Pharmaceutical Inc. | Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors |
| CN104341345B (zh) * | 2014-10-24 | 2016-03-23 | 海门海康生物医药科技有限公司 | 一种2-甲氧基-6-酮-5,6,7,8-四氢喹啉的合成方法 |
| JP7413346B2 (ja) | 2019-03-06 | 2024-01-15 | 第一三共株式会社 | ピロロピラゾール誘導体 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1094353C (zh) * | 1994-04-25 | 2002-11-20 | 史密斯克莱·比奇曼公司 | 含有β－内酰胺酶抑制性青霉烯与β－内酰胺抗生素复合的药物制剂及其在治疗细菌感染中的应用 |
| US20040132706A1 (en) * | 2001-10-05 | 2004-07-08 | Daniela Salvemini | Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| US20040132708A1 (en) * | 2002-05-01 | 2004-07-08 | Wyeth | Process for preparing 6-alkylidene penem derivatives |
| AR039476A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | Proceso para preparar derivados de 6-alquiliden penem |
| AR039774A1 (es) * | 2002-05-01 | 2005-03-02 | Wyeth Corp | 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas |
| AR039475A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa |
| TW200716102A (en) * | 2005-06-01 | 2007-05-01 | Wyeth Corp | Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors |
-
2006
- 2006-05-22 TW TW095118171A patent/TW200716104A/zh unknown
- 2006-05-25 MX MX2007015173A patent/MX2007015173A/es unknown
- 2006-05-25 AU AU2006287938A patent/AU2006287938A1/en not_active Abandoned
- 2006-05-25 EP EP06824758A patent/EP1885358A2/en not_active Withdrawn
- 2006-05-25 CN CNA2006800193154A patent/CN101189010A/zh active Pending
- 2006-05-25 JP JP2008514712A patent/JP2008542376A/ja not_active Withdrawn
- 2006-05-25 CA CA002610478A patent/CA2610478A1/en not_active Abandoned
- 2006-05-25 WO PCT/US2006/020410 patent/WO2007030166A2/en not_active Ceased
- 2006-05-25 BR BRPI0611491-1A patent/BRPI0611491A2/pt not_active IP Right Cessation
- 2006-05-31 US US11/444,346 patent/US20060276446A1/en not_active Abandoned
- 2006-05-31 SV SV2006002555A patent/SV2007002555A/es unknown
- 2006-05-31 PE PE2006000563A patent/PE20070010A1/es not_active Application Discontinuation
- 2006-06-01 AR ARP060102292A patent/AR054467A1/es unknown
- 2006-06-01 GT GT200600235A patent/GT200600235A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR054467A1 (es) | 2007-06-27 |
| EP1885358A2 (en) | 2008-02-13 |
| MX2007015173A (es) | 2008-02-15 |
| TW200716104A (en) | 2007-05-01 |
| JP2008542376A (ja) | 2008-11-27 |
| US20060276446A1 (en) | 2006-12-07 |
| CA2610478A1 (en) | 2007-03-15 |
| AU2006287938A1 (en) | 2007-03-15 |
| WO2007030166A3 (en) | 2007-05-24 |
| WO2007030166A2 (en) | 2007-03-15 |
| SV2007002555A (es) | 2007-02-02 |
| BRPI0611491A2 (pt) | 2010-12-21 |
| CN101189010A (zh) | 2008-05-28 |
| GT200600235A (es) | 2007-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20110122A1 (es) | COMPUESTOS DERIVADOS DE 9H-PIRROLO[2,3-b:5,4-c]DIPIRIDIN-6-(PIRIDIN-3-IL) COMO INHIBIDORES DE LAS CINASA Pim | |
| PE20171341A1 (es) | Compuestos de pirazina para el tratamiento de enfermedades infecciosas | |
| PE20090511A1 (es) | Imidazopiridinonas | |
| PE20130346A1 (es) | Compuestos heterociclicos fusionados | |
| PE20091833A1 (es) | Derivados heterociclicos espiro biciclicos o heterociclicos biciclicos, puenteados, de pirazolo [1,5-a]pirimidinas como inhibidores de quinasas raf y metodos para su preparacion | |
| PE20120505A1 (es) | Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona como moduladores de pde9a | |
| PE20110387A1 (es) | Aminotriazolo-piridinas como inhibidores de cinasa | |
| PE20090370A1 (es) | Derivados de heterociclo fusionado como inhibidores de quinasa | |
| PE20071104A1 (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv (dpp-4) | |
| EA201170771A1 (ru) | Органические соединения | |
| PE20070367A1 (es) | Compuestos de espiropiperidina como inhibidores de la enzima beta secretasa | |
| PE20080931A1 (es) | Imidazopirazinas como inhibidores de proteina quinasa | |
| PE20110545A1 (es) | Compuestos de triazolopiridina como inhibidores de jak | |
| PE20110296A1 (es) | Compuestos heterociclicos fusionados como moduladores del receptor de orexina | |
| PE20090648A1 (es) | Compuestos para el tratamiento de la hepatitis c | |
| PE20061484A1 (es) | Compuestos triciclicos fusionados como inhibidores de la actividad de quinesina de ksp | |
| PE20091039A1 (es) | IMIDAZO PIRAZINAS FUSIONADAS ARILO Y HETEROARILO [1,5-a] COMO INHIBIDORES DE LA FOSFODIESTERASA 10 | |
| PE20171342A1 (es) | Compuestos y su uso como inhibidores de bace | |
| PE20140970A1 (es) | Derivados de 6-ciclobutil-1,5-dihidro-pirazol [3,4-d) pirimidin-4-ona y su uso como inhibidores de pde9a | |
| PE20121438A1 (es) | Derivados de imidazopiridina o imidazopirimidina como inhibidores de fosfodiesterasa 10a | |
| PE20051094A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico y procesos para su preparacion | |
| PE20070010A1 (es) | Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d | |
| JO3611B1 (ar) | سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم | |
| PE20080145A1 (es) | Tetrahidro-pirimidoazepinas como moduladores de trpv1 | |
| PE20081753A1 (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |